The U.S. Interventional Radiology Market is expected to witness significant growth during the forecast period due to factors such as increase in preference for minimally invasive imaging guided procedures and rise in prevalence of chronic diseases such as cancer, blood vessel diseases, and others. In addition, introduction of novel technologies such as fractional flow reserve, thrombectomy technologies, and intra-vascular ultrasound technology is expected to drive the growth of the U.S interventional radiology market. However, implementation of stringent regulatory procedures for approval of interventional radiology devices and their high cost are the major factors anticipated to restrain the market growth.
On the contrary, recent advancements and increase in applications & launches of interventional radiology accessories in the U.S. are projected to offer remunerative opportunities for market expansion during the forecast period. For instance, Philips launched a new IntraSight interventional application-based platform, which offers the fractional flow reserve (FFR) and intravascular ultrasound (IVUS) for image-guided treatments of the heart and peripheral blood vessels. In addition, Embolx received an FDA approval for the next-generation sniper balloon occlusion microcatheter, which is available in three lengths 110, 130, and 150 cm and enables the advanced navigation through radial arterial access and complex vascular structures. Furthermore, ion endoluminal system provided by the Intuitive Surgical Inc. received the U.S. Food and Drug Administration (FDA) clearance that enables minimally invasive biopsy in peripheral lung.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-toc-and-sample/4873
The U.S. interventional-radiology market is segmented into product, procedure, application, and end user. On the basis of product, the market is categorized into MRI system ultrasound imaging system, CT scanner, angiography system, fluoroscopy system, and biopsy system. By procedure, it is divided into angiography, balloon angioplasty, embolization, biopsy, vertebroplasty–kyphoplasty, and RF ablation. The applications covered in the study include oncology, cardiology, urology & nephrology, and gastroenterology. Depending on end user, the market is fragmented into hospitals, catheterization labs, and ambulatory surgical centers.
The key players operating in the U.S. interventional-radiology market include GENERAL ELECTRIC, Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, Esaote SpA, Hologic, Inc., Shimadzu Corporation and Samsung Medison Co., Ltd., and Siemens Healthcare Diagnostics, Inc. Other players profiled in the report are Embolx, Inc., Cardinal Health, B. Braun Melsungen AG, BD, Stryker, and Cook.
Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4873
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current interventional radiology market trends and future estimations from 2019 to 2026, which assist to identify the prevailing opportunities.
- A comprehensive analysis of the factors that drive and restrain the growth of the global interventional radiology market is provided.
- Region-wise and country-wise market conditions are comprehensively analyzed in this report.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.